During the past decade, Seattle Prostate Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seattle Prostate Institute" #1 collaborator was "Kent E. Wallner, M.D." with 1 trials as a collaborator, "National Institute of Nursing Research (NINR)" with 1 trials as a collaborator, "Sylvester, John, M.D." with 1 trials as a collaborator and "University of Washington" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Seattle Prostate Institute" are "Prostate Cancer" (2 trials). Many other conditions were trialed in "Seattle Prostate Institute" in a lesser frequency.

Most popular intervention types in "Seattle Prostate Institute" are "Behavioral" (1 trials), "Drug" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Casodex" (1 trials), "External beam radiation" (1 trials), "Lupron" (1 trials) and "P4" (1 trials). Other intervention names were less common.

The vast majority of trials in "Seattle Prostate Institute" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Seattle Prostate Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Seattle Prostate Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Seattle Prostate Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".